在马术比赛中是否应该允许使用奥梅普拉?
Madeleine L H Campbell1, Benjamin W Sykes2
1School of Veterinary Medicine and Science, University of Nottingham, Loughborough, UK.
Equine veterinary journal
|July 12, 2024
概括
建议在比赛日允许奥梅普拉 (一种治疗马胃综合征的药物) 用于比赛之外接受治疗的马. 这确保了马的福利,并需要更新伦理马术运动的法规.
科学领域:
- 马体育科学与伦理学 马体育科学与伦理
- 动物福利和监管政策
背景情况:
- 保持公众对马术运动的信任和社会许可需要优先考虑马匹福利,基于证据的政策和一致的决策.
- 关于在竞争中使用奥梅普拉的不同法规引起了利益相关者和公众的担忧.
研究的目的:
- 评估允许在马术比赛期间使用欧梅普拉的伦理允许性.
- 关于在运动中使用马匹的坎贝尔伦理框架的应用以指导政策建议.
主要方法:
- 进行了一项全面的伦理法律研究.
- 坎贝尔的道德框架被系统地应用,包括证据分析,利益相关者的利益考虑和危害益处评估.
主要成果:
- 马胃综合征 (EGUS) 在竞赛马中很普遍,奥梅普拉是主要治疗方法.
- 最近的证据表明,仅在比赛日保留奥梅普拉,不会导致EGUS的复发,而不是在比赛前两天保留它.
- 目前关于在比赛期间使用欧梅普拉的规定在不同的管理机构之间不一致.
结论:
- 根据当前的科学证据,允许在比赛日对赛马进行治疗是合理的,因为 horses 在比赛之外接受治疗的马的福利.
- 管理机构必须修订有关在比赛期间使用奥梅普拉的规定,以确保伦理实践和保护马的福利.
- 需要进一步的研究来探索非竞争性梅治疗对福利的潜在影响.
相关概念视频
Peptic Ulcer Disease IV: Management
85
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
85
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
365
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
365
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
395
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
395
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
415
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
415
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
435
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
435
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
348
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
348


